Company Overview of Sinapis Pharma, Inc.
Sinapis Pharma, Inc. operates as a clinical stage biotechnology company that develops Methamphetamine, an intravenous neuroprotective agent for treating stroke, traumatic brain injury, and other ischemic and traumatic conditions in patients. The company was founded in 2009 and is based in Jacksonville, Florida.
4350 Pablo Professional Court
Jacksonville, FL 32224
Founded in 2009
Key Executives for Sinapis Pharma, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Sinapis Pharma, Inc., please visit www.sinapispharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.